CD14 promoter-159 polymorphism is associated with reduced risk of intestinal-type gastric cancer in a japanese population

  • Tomomitsu Tahara
  • , Tomoyuki Shibata
  • , Ichiro Hirata
  • , Hiroshi Nakano
  • , Tomiyasu Arisawa

Research output: Contribution to journal › Article › peer-review

11 Citations (Scopus)

Fingerprint

Dive into the research topics of 'CD14 promoter-159 polymorphism is associated with reduced risk of intestinal-type gastric cancer in a japanese population'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology